Home
MRK
MRK News

Latest Merck & Company Inc. (new) (MRK) News on April 2, 2025

Merck to Hold First-Quarter 2025 Sales and Earnings Conference Call April 24

Business Wire

a day ago

Merck to Hold First-Quarter 2025 Sales and Earnings Conference Call April 24

Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?

Investor's Business Daily

2 days ago

Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?

Merck (NYSE:MRK) Reports Strong Phase 3 Results For WINREVAIR In PAH Treatment

Simply Wall St.

2 days ago

Merck (NYSE:MRK) Reports Strong Phase 3 Results For WINREVAIR In PAH Treatment

WINREVAIR™ (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the Phase 3 ZENITH Trial

Business Wire

2 days ago

WINREVAIR™ (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the Phase 3 ZENITH Trial

Why Merck & Co. Inc. (MRK) Went Up On Friday?

Insider Monkey

4 days ago

Why Merck & Co. Inc. (MRK) Went Up On Friday?

China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market

Investor's Business Daily

5 days ago

China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market

FDA Accepts Merck's Filing for Subcutaneous Version of Keytruda

Zacks

5 days ago

FDA Accepts Merck's Filing for Subcutaneous Version of Keytruda

Is Merck & Co. (MRK) the Low Volatility Stock to Buy According to Billionaire Ken Fisher?

Insider Monkey

5 days ago

Is Merck & Co. (MRK) the Low Volatility Stock to Buy According to Billionaire Ken Fisher?

Merck's Biggest Moneymaker Could Get Even Bigger. But Will It Help Downtrodden Shares?

Investor's Business Daily

6 days ago

Merck's Biggest Moneymaker Could Get Even Bigger. But Will It Help Downtrodden Shares?

Merck releases positive data for blockbuster cancer drug

Yahoo Finance Video

6 days ago

Merck releases positive data for blockbuster cancer drug

Merck’s Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous (IV) KEYTRUDA® (pembrolizumab) in Pivotal 3475A-D77 Trial

Business Wire

6 days ago

Merck’s Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous (IV) KEYTRUDA® (pembrolizumab) in Pivotal 3475A-D77 Trial

Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form

Yahoo Finance

6 days ago

Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form

Here is Why Jim Cramer Is Bullish About Merck (MRK)

Insider Monkey

6 days ago

Here is Why Jim Cramer Is Bullish About Merck (MRK)

Is Merck & Co., Inc. (MRK) the Best Consistent Dividend Stock to Buy?

Insider Monkey

6 days ago

Is Merck & Co., Inc. (MRK) the Best Consistent Dividend Stock to Buy?

Jim Cramer on Merck (MRK): “I Like It at This Level – But I Like Bristol-Myers Even More!”

Insider Monkey

7 days ago

Jim Cramer on Merck (MRK): “I Like It at This Level – But I Like Bristol-Myers Even More!”

Merck (NYSE:MRK) Gains EC Approval For CAPVAXIVE® Amid Recent 7% Share Price Dip

Simply Wall St.

7 days ago

Merck (NYSE:MRK) Gains EC Approval For CAPVAXIVE® Amid Recent 7% Share Price Dip

European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

Business Wire

7 days ago

European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

Why Merck & Co. Inc. (MRK) Performed Worst On Tuesday?

Insider Monkey

7 days ago

Why Merck & Co. Inc. (MRK) Performed Worst On Tuesday?

Is Merck & Co. Inc. (MRK) The Best Defensive Stock Amid Market Volatility?

Insider Monkey

7 days ago

Is Merck & Co. Inc. (MRK) The Best Defensive Stock Amid Market Volatility?

Merck Bets $2B on China's Hengrui for Next Big Heart Drug

GuruFocus.com

8 days ago

Merck Bets $2B on China's Hengrui for Next Big Heart Drug

Merck Will Pay Up to $2 Billion for Chinese Heart Drug

Bloomberg

8 days ago

Merck Will Pay Up to $2 Billion for Chinese Heart Drug

Trump tariffs drive pharma manufacturing to US but risk inflation and disruption

Pharmaceutical Technology

8 days ago

Trump tariffs drive pharma manufacturing to US but risk inflation and disruption

Is Weakness In Merck & Co., Inc. (NYSE:MRK) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Simply Wall St.

8 days ago

Is Weakness In Merck & Co., Inc. (NYSE:MRK) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Merck bets $200M on a new type of heart pill

BioPharma Dive

8 days ago

Merck bets $200M on a new type of heart pill

Is Merck & Co. (MRK) The Best Healthcare Dividend Stock to Invest in?

Insider Monkey

9 days ago

Is Merck & Co. (MRK) The Best Healthcare Dividend Stock to Invest in?

1 Value Stock with Solid Fundamentals and 2 to Turn Down

StockStory

9 days ago

1 Value Stock with Solid Fundamentals and 2 to Turn Down

Merck & Co. (MRK): Among Stocks Insiders Were Piling Into Recently

Insider Monkey

11 days ago

Merck & Co. (MRK): Among Stocks Insiders Were Piling Into Recently

3 of Goldman Sachs' best investing tips for currently volatile markets

Yahoo Finance

12 days ago

3 of Goldman Sachs' best investing tips for currently volatile markets

Merck (NYSE:MRK) Unveils New Data On Cardiovascular Advances At ACC.25 Annual Conference

Simply Wall St.

13 days ago

Merck (NYSE:MRK) Unveils New Data On Cardiovascular Advances At ACC.25 Annual Conference

Merck & Co., Inc. (MRK): Among Incredibly Cheap Dividend Stock to Buy Now

Insider Monkey

13 days ago

Merck & Co., Inc. (MRK): Among Incredibly Cheap Dividend Stock to Buy Now

Argus Research

14 days ago

Analyst Report: Merck & Co Inc

Argus Research

14 days ago

Market Update: AEE, TT, MRK, NVDA

Why Merck & Co. (MRK) Is Among the Most Undervalued Biotech Stocks to Invest In

Insider Monkey

14 days ago

Why Merck & Co. (MRK) Is Among the Most Undervalued Biotech Stocks to Invest In

Merck Loses Almost $52B in 6 Months: How to Play MRK Stock

Zacks

14 days ago

Merck Loses Almost $52B in 6 Months: How to Play MRK Stock

Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination

TipRanks

14 days ago

Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy

CNW Group

14 days ago

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy

Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease

Business Wire

14 days ago

Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease

Merck & Co., Inc. (MRK): A Bull Case Theory

Insider Monkey

15 days ago

Merck & Co., Inc. (MRK): A Bull Case Theory

Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued S&P 500 Stock to Buy Now?

Insider Monkey

15 days ago

Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued S&P 500 Stock to Buy Now?

Is Merck & Co Inc. (NYSE:MRK) the Most Profitable Value Stock to Buy Now?

Insider Monkey

16 days ago

Is Merck & Co Inc. (NYSE:MRK) the Most Profitable Value Stock to Buy Now?

Merck & Co., Inc. (MRK): Among Top Dividend Contenders List

Insider Monkey

17 days ago

Merck & Co., Inc. (MRK): Among Top Dividend Contenders List

MSD to push for approval of HIV combo after Phase III success

Clinical Trials Arena

20 days ago

MSD to push for approval of HIV combo after Phase III success

Merck & Co., Inc. (NYSE:MRK) Looks Interesting, And It's About To Pay A Dividend

Simply Wall St.

20 days ago

Merck & Co., Inc. (NYSE:MRK) Looks Interesting, And It's About To Pay A Dividend

Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds

Insider Monkey

21 days ago

Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds

Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025

Benzinga

21 days ago

Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025

Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48

Business Wire

21 days ago

Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48

Merck & Co., Inc. (MRK): Among Dobermans of the Dow to Buy

Insider Monkey

21 days ago

Merck & Co., Inc. (MRK): Among Dobermans of the Dow to Buy

Merck (NYSE:MRK) Unveils US$1 Billion Durham Facility For Advanced Vaccine Manufacturing Expansion

Simply Wall St.

22 days ago

Merck (NYSE:MRK) Unveils US$1 Billion Durham Facility For Advanced Vaccine Manufacturing Expansion

Zacks Investment Ideas feature highlights: Molson Coors, Merck & Co. and Deutsche Telekom

Zacks

22 days ago

Zacks Investment Ideas feature highlights: Molson Coors, Merck & Co. and Deutsche Telekom

Merck opens $1B vaccine plant in North Carolina

BioPharma Dive

22 days ago

Merck opens $1B vaccine plant in North Carolina

Merck Unveils New Facility to Increase Vaccine Production Capacity

Business Wire

22 days ago

Merck Unveils New Facility to Increase Vaccine Production Capacity

Merck & Co. (MRK): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now

Insider Monkey

22 days ago

Merck & Co. (MRK): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now

Wall Street Analysts Think This Medical Dividend Stock Could Have Massive 82% Upside

Benzinga

22 days ago

Wall Street Analysts Think This Medical Dividend Stock Could Have Massive 82% Upside

Merck & Co. (MRK): One of the Most Undervalued US Stocks to Buy According to Hedge Funds

Insider Monkey

23 days ago

Merck & Co. (MRK): One of the Most Undervalued US Stocks to Buy According to Hedge Funds

Safe Haven Stocks: 3 Top Picks for Navigating Volatility

Zacks

23 days ago

Safe Haven Stocks: 3 Top Picks for Navigating Volatility

Stock market sell-off: Why these stocks are in the green amid the pain

Yahoo Finance

23 days ago

Stock market sell-off: Why these stocks are in the green amid the pain

Is Merck & Co., Inc. (MRK) the Most Undervalued High Quality Stock to Buy According to Analysts?

Insider Monkey

24 days ago

Is Merck & Co., Inc. (MRK) the Most Undervalued High Quality Stock to Buy According to Analysts?

Merck & Co., Inc. (MRK) Among The Best Cheap Dividend Stock To Buy Right Now

Insider Monkey

25 days ago

Merck & Co., Inc. (MRK) Among The Best Cheap Dividend Stock To Buy Right Now

CDC plans study into potential vaccines, autism connections, Reuters reports

TipRanks

25 days ago

CDC plans study into potential vaccines, autism connections, Reuters reports

Merck & Co. (MRK): Among the Best Undervalued Stocks to Invest In Now

Insider Monkey

a month ago

Merck & Co. (MRK): Among the Best Undervalued Stocks to Invest In Now

Merck (MRK) Up 3.9% Since Last Earnings Report: Can It Continue?

Zacks

a month ago

Merck (MRK) Up 3.9% Since Last Earnings Report: Can It Continue?

Merck & Co. (MRK): An Undervalued Wide Moat Stock to Buy According to Analysts

Insider Monkey

a month ago

Merck & Co. (MRK): An Undervalued Wide Moat Stock to Buy According to Analysts

New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle

The Wall Street Journal

a month ago

New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle

Is Merck & Co., Inc. (MRK) The Best Immunology Stock To Buy Now?

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) The Best Immunology Stock To Buy Now?

Merck & Co. (MRK): One of the Best Psychedelic Stocks to Buy in 2025

Insider Monkey

a month ago

Merck & Co. (MRK): One of the Best Psychedelic Stocks to Buy in 2025

Is Merck & Co., Inc. (MRK) the Best Dividend Stock to Buy According to Billionaires?

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) the Best Dividend Stock to Buy According to Billionaires?

Merck's (NYSE:MRK) Earnings May Just Be The Starting Point

Simply Wall St.

a month ago

Merck's (NYSE:MRK) Earnings May Just Be The Starting Point

Blocking PD-1 and VEGF: The bispecific cancer drugs that could best Keytruda

BioPharma Dive

a month ago

Blocking PD-1 and VEGF: The bispecific cancer drugs that could best Keytruda

Merck & Co., Inc. (MRK): Among the Best Affordable Dividend Stocks to Buy According to Hedge Funds

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): Among the Best Affordable Dividend Stocks to Buy According to Hedge Funds

Is Merck & Co., Inc. (MRK) the Best Magic Formula Stock for 2025?

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) the Best Magic Formula Stock for 2025?

Thomson Reuters StreetEvents

a month ago

Q4 2024 OPKO Health Inc Earnings Call

Merck Slips 8% in a Month: Should You Buy, Hold or Sell the Stock?

Zacks

a month ago

Merck Slips 8% in a Month: Should You Buy, Hold or Sell the Stock?

Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Simply Wall St.

a month ago

Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

MT Newswires

a month ago

Berenberg Lowers Price Target on Merck to $115 From $125, Keeps Buy Rating

Merck & Co., Inc. (MRK): One of the Best Vaccine Stocks to Buy According to Hedge Funds

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): One of the Best Vaccine Stocks to Buy According to Hedge Funds

3 Leading Dividend Stocks To Consider With Up To 5.6% Yield

Simply Wall St.

a month ago

3 Leading Dividend Stocks To Consider With Up To 5.6% Yield

Is Merck & Co., Inc. (MRK) the Best Retirement Stock to Buy According to Hedge Funds?

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) the Best Retirement Stock to Buy According to Hedge Funds?

Why Polaris, Merck, And Skyworks Solutions Are Winners For Passive Income

Benzinga

a month ago

Why Polaris, Merck, And Skyworks Solutions Are Winners For Passive Income

Merck & Co., Inc. (MRK): Among Bourgeon Capital’s Top Stock Picks

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): Among Bourgeon Capital’s Top Stock Picks

Despite delivering investors losses of 27% over the past 1 year, Merck (NYSE:MRK) has been growing its earnings

Simply Wall St.

a month ago

Despite delivering investors losses of 27% over the past 1 year, Merck (NYSE:MRK) has been growing its earnings

Cancer vaccines have stumbled, but the approach is gaining new steam

Pharma Voice

a month ago

Cancer vaccines have stumbled, but the approach is gaining new steam

Eikon raises $351M in one of the year’s largest biotech venture rounds

BioPharma Dive

a month ago

Eikon raises $351M in one of the year’s largest biotech venture rounds

Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Maybe The Ultimate Laggard’

Insider Monkey

a month ago

Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Maybe The Ultimate Laggard’

Wall Street Analysts See Merck (MRK) as a Buy: Should You Invest?

Zacks

a month ago

Wall Street Analysts See Merck (MRK) as a Buy: Should You Invest?

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Business Wire

a month ago

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

5 Stocks in the Dow ETF That Survived the Worst Week Since October

Zacks

a month ago

5 Stocks in the Dow ETF That Survived the Worst Week Since October

Merck to Participate in the TD Cowen 45th Annual Health Care Conference

Business Wire

a month ago

Merck to Participate in the TD Cowen 45th Annual Health Care Conference

Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Merck & Co., Inc. (MRK): Among the Most Expensive Stocks Insiders Are Buying Recently

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): Among the Most Expensive Stocks Insiders Are Buying Recently

2 Healthcare Stocks with Big Upside and 1 to Skip

StockStory

a month ago

2 Healthcare Stocks with Big Upside and 1 to Skip

MT Newswires

a month ago

Merck & Co. Insider Sold Shares Worth $714,745, According to a Recent SEC Filing

Merck & Co., Inc. (MRK): Among the Cheap High Dividend Stocks to Invest In Now

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): Among the Cheap High Dividend Stocks to Invest In Now

Is Merck & Co., Inc. (MRK) the Best Very Cheap Stock To Buy Right Now?

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) the Best Very Cheap Stock To Buy Right Now?

Europe Approves Merck's Cancer Drug For Two Indications

Benzinga

a month ago

Europe Approves Merck's Cancer Drug For Two Indications

Merck & Co., Inc. (MRK): Among the Best Drug Stocks to Buy Now

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): Among the Best Drug Stocks to Buy Now

WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications

Business Wire

a month ago

WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications

Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?

Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes

Insider Monkey

2 months ago

Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes

MT Newswires

2 months ago

Merck & Co. Insider Sold Shares Worth $512,057, According to a Recent SEC Filing

Morningstar Research

2 months ago

Analyst Report: Merck & Co., Inc.

Share on Social Networks: